Ncardia Employee Directory
Biotechnology ResearchSouth Holland, Netherlands11-50 Employees
Ncardia is a biotechnology company based in Leiden, Netherlands, specializing in drug discovery and human induced pluripotent stem cell (iPSC) technology. It operates across Europe and North America, collaborating with biopharmaceutical companies to apply stem cell-derived models at any development stage and across multiple modalities. The company has built expertise to differentiate, manufacture, and characterize iPSC-derived cells and disease models, enabling disease modeling and high-throughput screening to support drug discovery. It emphasizes listening to customer plans and co-developing iPSC-based solutions tailored to specific project requirements. A notable recent development is the 2025 launch of Ncyte NHP-C vCardiomyocytes, the first commercially available ventricular-like cardiomyocytes derived from iPSCs of cynomolgus monkeys.